RESEARCH-USE BIOSIMILAR ANTIBODY
Cemiplimab
Monoclonal antibody · IgG4
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-682
CATALOG NUMBERSC-BS-682
MOLECULAR WEIGHTApprox. 143.57 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research.
Cemiplimab is a recombinant research-use antibody directed against PDCD1.